uncontrolled hypertension

Related by string. Uncontrolled hypertension * Uncontrolled : uncontrolled gusher . uncontrolled blowout . uncontrolled seizures . uncontrolled acceleration . airspace uncontrolled / Hypertension . HYPERTENSION : pulmonary arterial hypertension PAH . pulmonary arterial hypertension . persistent pulmonary hypertension . diabetes hypertension . hypertension diabetes * *

Related by context. All words. (Click for frequent words.) 66 stable angina 66 silent ischemia 65 NYHA Class II 65 ATACAND 65 elevated triglyceride levels 64 renal impairment 64 decompensated heart failure 64 asymptomatic PAD 64 angina chest 64 macrovascular disease 63 preserved ejection fraction 63 ischemic cardiomyopathy 63 hypertension 63 NATRECOR ® 63 microvascular disease 63 Avandia Actos 63 lipid lowering medications 62 arterial thromboembolic events 62 loop diuretics 62 CYPHER Stent 62 Nesiritide 62 Prehypertension 62 benazepril 62 renal dysfunction 62 systolic dysfunction 62 hemorrhagic strokes 62 renal insufficiency 62 thromboembolic 62 atherothrombosis 61 left ventricular hypertrophy 61 NATRECOR R 61 coronary blockages 61 haemorrhagic stroke 61 symptomatic BPH 61 atherothrombotic disease 61 dyslipidaemia 61 β blockers 61 systolic hypertension 61 NYHA Class III 61 HeFH 61 hypertensives 61 coronary revascularization procedures 61 angiotensin receptor blockers ARBs 61 left ventricular dysfunction 61 severe aortic stenosis 61 Erythropoietic therapies may 61 carotid artery blockage 61 antihypertensive drugs 61 thrombotic events 61 overactive bladder symptoms 61 postoperative atrial fibrillation 61 #mmHg [001] 61 abnormal lipids 60 subclinical hypothyroidism 60 myocardial ischemia 60 antihypertensive medications 60 rhythm disturbances 60 TNF antagonist 60 prescribed statins 60 poor metabolizers 60 diastolic blood pressures 60 CVD mortality 60 suboptimal adherence 60 nonvertebral fracture 60 acute myocardial infarction AMI 60 angina pectoris 60 LV dysfunction 60 ADHF 60 beta blocker therapy 60 infarctions 60 orthostatic hypotension 60 non valvular atrial 60 thrombocytopenic 60 CRVO 60 familial hypercholesterolemia 60 rosuvastatin Crestor 60 antihypertensives 60 prolonged QT interval 60 uncontrolled asthma 60 thromboembolic complications 60 aldosterone antagonist 60 hyperkalemia 60 oral antidiabetes 60 Atacand 60 baseline HbA1c 59 coronary artery disease 59 post thrombotic syndrome 59 Exacerbations 59 antihypertensive therapy 59 peripheral arterial disease 59 Hp2 2 59 OAB symptoms 59 extrapyramidal symptoms 59 coronary revascularization 59 glitazones 59 riociguat 59 primary aldosteronism 59 renal artery stenosis 59 proliferative retinopathy 59 serum urate levels 59 candesartan cilexetil 59 Excessive daytime sleepiness 59 angiotensin converting enzyme inhibitors 59 bacterial prostatitis 59 dermatologic reactions 59 chronic thromboembolic pulmonary 59 arterial thickening 59 proliferative diabetic retinopathy 59 resynchronization therapy 59 Severe Primary IGFD 59 fragility fractures 59 nondiabetic patients 59 anticlotting drugs 59 isolated systolic hypertension 59 acute coronary syndromes 59 Subgroup analyzes 59 ACEIs 59 onset diabetes mellitus 59 hypercholesterolaemia 59 elevated IOP 59 Mitral regurgitation 59 olmesartan 59 TEAEs 59 unstable angina chest 59 elevated LDL cholesterol 59 acute myocardial infarction MI 59 neurologic complications 59 HIV HCV coinfected 59 rosuvastatin #mg 59 androgen deficiency 59 nonischemic 59 antiplatelet drugs 59 microbleeds 59 onset atrial fibrillation 59 untreated OSA 59 diabetic kidney 59 lipid lowering agents 59 thromboembolic disease 59 either acutely decompensated 59 chronic hepatitis cirrhosis 58 deep venous thromboses 58 irbesartan 58 sleep apneas 58 EDARBI 58 urolithiasis 58 NYHA class 58 cerebrovascular events 58 intracerebral haemorrhage 58 hyperlipidaemia 58 heterozygous FH 58 hypercholesterolemic patients 58 T1DM 58 AAT deficiency 58 pulmonary capillary wedge 58 ischemic strokes 58 artery stenosis 58 antiplatelet medications 58 ejection fractions 58 elevated triglycerides 58 clazosentan 58 unstable angina 58 impaired renal 58 Aortic stenosis 58 unstable angina pectoris 58 valvular heart disease 58 PRADAXA 58 comorbid illnesses 58 rFVIIa 58 Candesartan 58 reflux disease 58 psychiatric comorbidities 58 carotid plaque 58 recurrent ischemia 58 ALLHAT 58 hemodialysis patients 58 comorbid conditions 58 anemia neutropenia 58 chronic periodontitis 58 VIIBRYD 58 angina 58 antihypertensive agents 58 aortic valve stenosis 58 renal toxicity 58 recurrent stroke 58 undergoing CABG 58 Peripheral arterial disease 58 nonalcoholic steatohepatitis 58 elevated serum creatinine 58 failure NYHA 58 hypertensive patients 58 cardiac dysfunction 58 venlafaxine Effexor 58 AFib 58 retinal vein occlusion 58 acute phosphate nephropathy 58 elevated fasting glucose 58 decompensated liver disease 58 lipid disorders 58 dopaminergic therapy 58 PROactive study 58 symptomatic aortic stenosis 58 XIENCE V PROMUS Stent 58 slow metabolizers 58 elevated LDH 58 hypertension diabetes mellitus 58 fluvastatin 58 rhythm abnormalities 58 nonvertebral fractures 58 invasive candidiasis 58 subclinical atherosclerosis 58 microscopic hematuria 58 cardiovascular ischemic 58 underdiagnosis 58 myocardial infarction stroke 58 progressive dyspnea 58 beta blockers ACE inhibitors 58 chronic angina 58 myocardial infarctions 58 atherosclerotic disease 58 aspirin clopidogrel 58 glitazone 58 reoperations 58 attention-deficit/hyperactivity disorder ADHD 58 juvenile idiopathic arthritis 58 ruptured aneurysms 58 recurrent VTE 58 Lipitor #mg 58 β blocker 58 variant angina 58 anticholinergics 58 Heavy snorers 58 elevated uric acid 58 ACE Inhibitors 58 mild renal insufficiency 58 angiotensin receptor blockers 58 reflux symptoms 57 syncopal 57 typical antipsychotics 57 TMP SMX 57 lactic acidosis 57 recurrent wheezing 57 recurrent tonsillitis 57 oral antidiabetes drugs 57 MACCE 57 symptomatic carotid stenosis 57 untreated sleep apnea 57 cardioembolic stroke 57 Aceon 57 EXJADE 57 ticlopidine 57 newer antipsychotics 57 anticoagulants blood thinners 57 atherogenic dyslipidemia 57 chronic myocardial ischemia 57 percutaneous interventions 57 testosterone deficiency 57 cardiovascular disease 57 heart arrhythmias 57 angiotensin II receptor blockers 57 noncardiac surgery 57 Neovascular AMD 57 antidiabetic drugs 57 Cognitive impairment 57 hyperglycaemia 57 Statin therapy 57 candesartan 57 juvenile idiopathic arthritis JIA 57 carotid stenosis 57 left ventricular systolic 57 lupus nephritis 57 valvular disease 57 lumiracoxib 57 ACTOplus met XR 57 paroxysmal AF 57 retinal vein occlusion induced 57 liver transplant recipients 57 Torsades de Pointes 57 arterial stiffness 57 elevated CRP 57 valsartan 57 severe exacerbations 57 tolvaptan 57 bezafibrate 57 Heavy menstrual bleeding 57 cytopenias 57 Novartis Diovan 57 intracerebral hemorrhage 57 cardiovascular mortality 57 dysglycemia 57 mildly symptomatic 57 COPD exacerbation 57 androgen excess 57 PLX STROKE targeting 57 baseline serum creatinine 57 microalbuminuria 57 chronic metabolic acidosis 57 aortic stenosis 57 KETEK 57 diastolic heart 57 elevated ALT 57 oral antidiabetic medication 57 ischemic stroke 57 APTIVUS r 57 lipid lowering drugs 57 resistant hypertension 57 Eisenmenger syndrome 57 gastrointestinal GI bleeding 57 macrovascular events 57 PREZISTA r 57 partial onset seizures 57 revascularization procedures 57 PREZISTA r arm 57 Proteinuria 57 receiving XGEVA 57 Retisert TM 57 failure ADHF 57 AVANDIA 57 prednisone prednisolone 57 polyp recurrence 57 refractory angina 57 pulmonary arterial hypertension 57 Serious adverse reactions 57 generalized edema 57 undiagnosed untreated 57 glomerular filtration 57 NNT = 57 ACE inhibitors 57 symptomatic hyponatremia 57 neurologic symptoms 57 Ischemic stroke 57 testosterone supplementation 57 relapsed MM 57 Thrombocytopenia 57 asymptomatic carotid stenosis 57 lipid lowering therapy 57 artery blockages 57 T2DM 57 Chronic Constipation 57 neovascular glaucoma 57 leukopenia 57 Hypotension 57 thrombolytic therapy 57 NYHA functional class 57 macular edema 57 mixed hyperlipidemia 57 intermittent claudication 57 hypoglycemic episodes 57 nonadherence 57 acute coronary syndromes ACS 57 thiazide 57 detrusor overactivity 57 Prostatitis 57 chronic immune thrombocytopenic 57 PAOD 57 pyridostigmine 57 cardiac insufficiency 57 Critical limb ischemia 57 digoxin toxicity 57 angioplasties stents 57 Peripheral edema 57 subclinical hyperthyroidism 57 atrophic gastritis 57 CHD CVD 57 nonmelanoma skin cancers 57 overactive bladder OAB 57 microvascular complications 56 recurrent miscarriage 56 hypokalemia hypomagnesemia 56 NOMID 56 hepatitis C genotype 56 antiarrhythmic drugs 56 type2 diabetes 56 acute myocardial infarctions 56 dobutamine 56 macroalbuminuria 56 antiarrhythmic drug 56 NIASPAN 56 abnormal lipid 56 cardiovascular disease hypertension 56 neovascular AMD 56 acromegalic patients 56 revascularization procedure 56 Heterozygous Familial Hypercholesterolemia 56 atherothrombotic events 56 undergoing coronary artery 56 adult chronic ITP 56 Carvedilol 56 candidemia 56 endometrial hyperplasia 56 perioperative mortality 56 myopathy rhabdomyolysis 56 venous thromboembolic disease 56 diabetes mellitus DM 56 abnormal glucose tolerance 56 comorbidities 56 symptomatic paroxysmal AF 56 eosinophilic asthma 56 Primary IGFD 56 myocardial infarction MI 56 hyperphenylalaninemia HPA due 56 plasma homocysteine levels 56 circulating EPCs 56 primary generalized tonic 56 venous blood clots 56 atherosclerotic cardiovascular disease 56 Dyslipidemia 56 flutamide 56 fluid overload 56 cryptogenic stroke 56 aldosterone antagonists 56 cardiogenic shock 56 Infusion Reactions Severe 56 SJIA 56 RRMS patients 56 severe hypoglycaemia 56 prehypertension 56 ventricular arrhythmia 56 abnormal lipid levels 56 aminotransferases 56 haloperidol Haldol 56 angiotensin converting enzyme inhibitor 56 vasodilators 56 co morbidities 56 perioperatively 56 postoperative delirium 56 nesiritide 56 carotid plaques 56 analgesic medications 56 recurrent venous thromboembolism 56 cerebral oxygenation 56 Venous thromboembolism 56 homozygous familial hypercholesterolemia 56 ventricular tachyarrhythmia 56 chronic ITP 56 affective psychoses 56 Stent thrombosis 56 ß blockers 56 Vitamin B# deficiency 56 occlusive disease 56 neuropsychiatric symptoms 56 nontraumatic 56 hsCRP levels 56 concomitant medications 56 hereditary predisposition 56 enalapril 56 impaired cognition 56 DETROL LA 56 ARIXTRA 56 elevated intraocular pressure 56 pyrexia mucositis sepsis febrile 56 losartan Cozaar 56 systemic corticosteroid 56 CYPHER R Sirolimus eluting 56 del 5q MDS 56 Diovan HCT 56 ximelagatran 56 bypass grafting 56 nondepressed 56 optic neuropathy 56 electrolyte disturbances 56 OSAHS 56 diastolic pressures 56 containing abacavir 56 Hb A1C 56 nicardipine 56 hypoglycemic events 56 angiotensin converting enzyme ACE 56 antihypertensive medication 56 oxygen desaturation 56 KIF6 carriers 56 primary hypercholesterolemia 56 symptomatic fibroids 56 persistent pulmonary hypertension 56 coronary disease 56 recurrent miscarriages 56 retrograde ejaculation 56 titrated glipizide 56 serum phosphate 56 antidiabetic medication 56 revascularizations 56 ACCORD Lipid 56 Critical Limb Ischemia 56 LVSD 56 venous thromboembolic events 56 underwent CABG 56 CMV infection 56 alemtuzumab treated 56 underwent coronary angiography 56 noncardiovascular mortality 56 cerebrovascular accident 56 Primary Hypercholesterolemia 56 severe renal insufficiency 56 serum phosphorous 56 infective endocarditis 56 Telmisartan 56 cirrhotic patients 56 lipid parameters 56 somnolence sleepiness 56 vWD 56 gestational hypertension 56 PRADAXA #mg 56 anthracycline therapy 56 GH deficiency 56 non cirrhotic portal 56 untreated hypothyroidism 56 acarbose 56 postoperative pulmonary 56 transaminase elevations 56 solifenacin 56 paclitaxel eluting stents 56 thromboembolism 56 COREG 56 conventional antipsychotics 56 metformin sulfonylurea 56 bloodpressure 56 bardoxolone methyl 56 darapladib 56 severe hepatic dysfunction 56 carotid artery disease 56 Hemorrhagic strokes 56 neutropenia dehydration dyspnea 56 labetalol 56 silent myocardial ischemia 56 migraineurs 56 thiazide diuretics 56 recurrent atrial fibrillation 56 AVODART 56 Bucindolol 56 idiopathic generalized epilepsy 56 intravitreal injections 56 Starlix 56 VTE prophylaxis 56 nonfatal MI 56 venous thromboembolism 56 daytime drowsiness 56 glucocorticoid therapy 56 intravenous bisphosphonates 56 cardiovascular hospitalization 56 microangiopathy 56 episodic migraine 56 hypotension 56 Overactive Bladder 56 lipohypertrophy 56 patients undergoing CABG 55 nonalcoholic steatohepatitis NASH 55 acute urinary retention 55 Personal CGM 55 hypercalcemia 55 salmeterol fluticasone 55 Myocardial infarction 55 rimonabant #mg 55 idiopathic pulmonary arterial hypertension 55 vascular disease 55 reinfarction 55 antithrombotics 55 VADT 55 beta carotene supplementation 55 Critical Limb Ischemia CLI 55 Uncontrolled hypertension 55 Diabetic Macular Edema 55 Relapsed Multiple Myeloma 55 INTEGRILIN R 55 upper gastrointestinal bleeding 55 benign prostatic hypertrophy 55 ruboxistaurin 55 Vitamin D insufficiency 55 ACTOplus met 55 recurrent DVT 55 venlafaxine XR 55 levosimendan 55 BENICAR HCT 55 glycated hemoglobin levels 55 hypoglycaemic episodes 55 symptomatic intracranial 55 Sleep disturbances 55 disordered breathing 55 Chronic ITP 55 Takeda Actos 55 gallstone disease 55 serum creatinine levels 55 cardiomyopathies 55 dapagliflozin plus 55 Stimulant drugs 55 nonmelanoma skin cancer 55 mmHg diastolic 55 severe hypoglycemic 55 smoldering multiple myeloma 55 DVT PE 55 induce orthostatic hypotension 55 drugs hydralazine 55 severe mitral regurgitation 55 transferrin saturation 55 intensive statin therapy 55 juvenile myoclonic epilepsy 55 Hip fracture 55 loop diuretic 55 coronary calcification 55 opioid dependent 55 intracranial atherosclerosis 55 antiepileptic drugs AEDs 55 receiving prophylactic anticoagulation 55 psychotherapeutic drugs 55 CP CPPS 55 hypercholesterolemia 55 acute coronary syndrome 55 AA Amyloidosis 55 endophthalmitis 55 PGTC seizures 55 perimenopausal women 55 hepatorenal syndrome 55 pravastatin Pravachol 55 mitral insufficiency 55 peptic ulcer 55 moderate renal impairment 55 HBV infections 55 nonfasting triglyceride levels 55 adrenal suppression 55 Valsartan 55 dentinal hypersensitivity 55 venous thromboembolisms 55 non aspirin NSAIDs 55 chlamydial infection 55 hyperglycemia 55 adrenal insufficiency 55 pegaptanib 55 glycated hemoglobin HbA1c 55 overt nephropathy 55 NPH insulin 55 prehypertensive 55 premature ejaculation PE 55 GERD symptoms 55 postural hypotension 55 recurrent UTI 55 debilitating complication 55 INVEGA ® 55 lipid levels 55 intractable epilepsy 55 hoFH patients 55 Testosterone deficiency 55 Eltrombopag 55 renal denervation 55 autonomic dysfunction 55 lipid abnormalities 55 elevated depressive symptoms 55 afib 55 ACTOS 55 metaglidasen 55 myocardial infarction ventricular fibrillation 55 insulin resistance syndrome 55 CABG surgeries 55 nonfatal myocardial infarction MI 55 acute ischemic stroke 55 asthma exacerbation 55 Major Depressive Disorder 55 metabolic acidosis 55 torsades de pointes 55 NHANES III 55 neutropenic patients 55 thiazolidinedione 55 noncardiac 55 MMSE scores 55 Rheumatoid Arthritis RA 55 lung resections 55 dyslipidemic 55 statin 55 diabetic macular edema 55 HIV lipodystrophy 55 Ischemic 55 white matter hyperintensities 55 gouty arthritis 55 unprovoked seizures 55 cholinesterase inhibitor 55 hypoglycemia unawareness 55 multivessel disease 55 psoriatic arthritis PsA 55 renovascular hypertension 55 cardiac repolarization 55 venous hypertension 55 ziprasidone Geodon 55 neurological complications 55 #mmHg [002] 55 mCRC acneform rash 55 infarction STEMI 55 occlusion CRVO 55 virologic failure 55 intracranial bleeding 55 TAXUS Liberte Stent 55 thromboembolic events 55 lichen planus 55 efalizumab 55 coronary artery blockages 55 oral antidiabetic drugs 55 Wisconsin Sleep Cohort 55 diabetes mellitus 55 cerebrovascular disease 55 trials RCTs 55 insulin sensitizing drugs 55 milrinone 55 advanced adenomas 55 paroxysmal atrial fibrillation 55 headache abdominal pain 55 oral hypoglycemic agents 55 ulcer healing 55 blood thinner apixaban 55 cirrhotic 55 hyperhydrosis 55 thrombotic thrombocytopenic purpura TTP 55 haemorrhagic strokes 55 carotid stents 55 ADPKD 55 anti arrhythmic drug 55 angiographic outcomes 55 C1 INH deficiency 55 Chronic constipation 55 HbA1c levels 55 thyroid deficiency 55 preserved systolic 55 MEVACOR 55 syncope 55 vasomotor symptoms 55 MERLIN TIMI 55 clevidipine 55 bowel polyps 55 non metastatic osteosarcoma 55 sulfonylurea metformin 55 AGILECT R 55 dysfunction LVSD 55 CRESTOR #mg 55 levodopa therapy 55 ACE inhibitor lisinopril 55 minimally symptomatic 55 peripheral artery disease 55 calcineurin inhibitor 55 Rofecoxib 55 postoperative AF 55 ivabradine 55 pantoprazole Protonix 55 intracranial stenosis 55 dyslipidemia 55 atherothrombotic 55 hyperlipemia 55 carotid atherosclerosis 55 MULTAQ 55 venous stasis ulcers 55 Rheos System 55 DU #b 55 inhaled glucocorticoids 55 Ischemic strokes 55 baseline A1C 55 oxycodone CR 55 AGGRASTAT ® tirofiban hydrochloride 55 Coronary artery disease 55 thienopyridines 55 BARACLUDE ® 55 perindopril 55 idiopathic PAH 55 open angle glaucoma 55 glyburide 55 Paxil paroxetine 55 LYSTEDA 55 parecoxib 55 amisulpride 55 lipid lowering medication 55 Hyperkalemia 55 agranulocytosis 55 beta blocker atenolol 55 MADIT II 55 vitamin D inadequacy 55 tamsulosin 55 oral FTY# 55 transdermal estrogen 55 GnRH agonists 55 QT prolongation 55 warfarin therapy 55 hypercalcaemia 55 ischemic vascular 55 serum uric acid 55 Subgroup analysis 55 everolimus eluting stents 55 polycystic ovary syndrome PCOS 54 potassium sparing diuretics 54 diastolic hypertension 54 fatigue shortness 54 pyelonephritis 54 Atypical Hemolytic Uremic Syndrome 54 cardiac malformations 54 #mm Hg 54 bacteriuria 54 severe obstructive sleep 54 erectile difficulties 54 primary immunodeficiency PI 54 carotid artery stenosis 54 obstructive sleep apnea 54 pulmonary dysfunction 54 tibolone 54 Lupus nephritis 54 heterozygous familial hypercholesterolemia 54 nondiabetics 54 severe hypotension 54 immune thrombocytopenic purpura 54 Hypertensive 54 abdominal adiposity 54 TMC# r 54 calcified plaques 54 thyrotropin levels 54 thyrotoxicosis 54 hypervolemic 54 Korsakoff syndrome 54 macular edema secondary 54 perioperative complications 54 Thiazolidinediones 54 comorbid ADHD 54 fibromyalgia syndrome 54 underwent liver transplantation 54 Ophena TM 54 Chronic Idiopathic Constipation 54 Diabetic neuropathy 54 CYPHER ® 54 subclinical cardiovascular disease 54 Topiramate 54 intravenous diuretics 54 NYHA 54 hemorrhagic complications 54 Prilosec omeprazole 54 thromboprophylaxis 54 impaired glucose tolerance 54 Atacand ® 54 serum phosphate levels 54 terlipressin 54 TZDs 54 hypokalemia 54 MGUS 54 abnormal Pap test 54 renal disease 54 tranylcypromine 54 mm Hg systolic 54 coxib 54 neurocognitive impairment 54 cerebral infarction 54 Juvenile Idiopathic Arthritis 54 Calcium intake 54 untreated obstructive sleep 54 PRISTIQ 54 dysfunctional voiding 54 thiazides 54 malignant neoplasm 54 Retisert 54 urinary tract symptoms 54 calcium antagonists 54 comorbid disorders 54 thiazide diuretic 54 ICDs implanted 54 SGPT 54 Elevated liver enzymes 54 nulliparous women 54 anginal symptoms 54 HbA 1c levels 54 generalized epilepsy 54 fragility fracture 54 ischemic cardiovascular 54 acne vulgaris 54 hypovolemic 54 sUA 54 QTc interval 54 elevated bilirubin 54 vitamin D insufficiency 54 recurrent angina 54 pathologic fractures 54 myocardial ischemic events 54 venous reflux 54 Captopril 54 Obstructive Sleep Apnea 54 QT interval prolongation 54 coexisting illnesses 54 ancrod 54 nonfatal stroke 54 tachyarrhythmias 54 anticholinergic medications 54 habitual snoring 54 Val HeFT 54 mycophenolate mofetil 54 risperidone Risperdal 54 untreated celiac disease 54 nephrotoxicity 54 Acute Decompensated Heart Failure 54 CLBP 54 somnolence fatigue 54 landmark ATHENA trial 54 RLAI 54 cardiovascular disease CVD 54 unresectable tumors 54 comorbid depression 54 cardiovascular hospitalizations 54 corticosteroid therapy 54 Ivabradine 54 severe asthma exacerbations 54 clozapine Clozaril 54 hardened arteries 54 chronic idiopathic thrombocytopenic purpura 54 intravascular hemolysis 54 receiving VELCADE 54 ACTEMRA TM 54 antiplatelets 54 allopurinol 54 patients undergoing percutaneous 54 glycosylated hemoglobin HbA1c 54 nonischemic cardiomyopathy 54 Lantus ® 54 tegaserod 54 ARCOXIA 54 neurogenic orthostatic hypotension 54 ALT flares 54 Vasotec 54 AIOD 54 statins 54 stenoses 54 hyperlipidemia 54 carotid IMT 54 PCNSL 54 canakinumab 54 undergoing radical prostatectomy 54 PASI scores 54 intra abdominal abscess 54 MTWA testing 54 post herpetic neuralgia PHN 54 Avanafil 54 severe neutropenia 54 empyema 54 ofpatients 54 vascular dysfunction 54 onset seizures 54 postoperative mortality 54 ramipril 54 proteinuria 54 defibrillator CRT D 54 elevated LDL 54 morphometric vertebral fractures 54 Paroxysmal Nocturnal Hemoglobinuria PNH 54 mm Hg diastolic 54 NYHA Class 54 clomipramine 54 chronic GVHD 54 intracranial hemorrhage ICH 54 recurrent glioblastoma multiforme 54 torsade de pointes 54 hepatitis B infection 54 beta blocker 54 bronchial hyperresponsiveness 54 Angioedema 54 premenstrual syndrome PMS 54 Loeys Dietz 54 hemorrhagic bleeding 54 hypercoagulable 54 visceral metastases 54 Renal impairment 54 nonfatal cardiovascular 54 systemic hypotension 54 HBeAg negative patients 54 plasma homocysteine 54 hypertensive 54 atrial fibrillation 54 TAXUS Stent 54 alpha blockers 54 Reversible Posterior Leukoencephalopathy Syndrome 54 sertraline Zoloft 54 diabetic neuropathic pain 54 abnormal genital 54 certolizumab 54 VTEs 54 severe renal impairment 54 calcineurin inhibitors 54 UA NSTEMI 54 Chronic Heart Failure 54 antiepileptic drug 54 electrolyte abnormalities 54 acute aortic dissection 54 alteplase 54 Acute Coronary Syndrome 54 BPH symptoms 54 hypogonadal men 54 nausea tiredness 54 Parnate 54 symptomatic hypotension 54 upper limb spasticity 54 telmisartan 54 psychiatric comorbidity 54 Subarachnoid hemorrhage 54 overactive bladders 54 heart disease 54 spine fractures 54 hemorrhagic stroke 54 drug eluting stent implantation 54 cholesterol lowering medication 54 gastrointestinal reflux 54 Venous stasis ulcers 54 Relapsing remitting MS 54 NSAID therapy 54 RAS blockers 54 IOP lowering

Back to home page